Vimarsana
Biggest News Aggregation in the World

Page 15 - Scientific Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Session Today - Breaking & Trending Today

Lupus Foundation of America Research Initiatives to be Presented at the 2022 American College of Rheumatology Annual Meeting - Vimarsana News

Lupus Foundation of America Research Initiatives to be Presented at the 2022 American College of Rheumatology Annual Meeting

/PRNewswire/ -- The American College of Rheumatology Convergence 2022 meeting will be held in Philadelphia, PA from November 10-14, 2022. The Lupus Foundation...

Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab(IBI306)in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022 - Vimarsana News

Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab(IBI306)in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022

/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

More than 50 Abstracts from Incyte's Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting - Vimarsana News

More than 50 Abstracts from Incyte's Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting

- Plenary Scientific Session to highlight Incyte-discovered novel anti-mutant CALR-targeted monoclonal antibody INCA033989 - Data from three of the Company's LIMBER studies evaluating ruxolitinib

Pros and Cons of Coffee and Heart Health - Vimarsana News

Pros and Cons of Coffee and Heart Health

Multiplying studies show health benefits for people who drink one or two cups of coffee a day, with some studies indicating up to four cups a day.

UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting - Vimarsana News

UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting

/PRNewswire/ -- UCB, a global biopharmaceutical company, announced today it is presenting results from across its portfolio in generalized myasthenia gravis...